verapamil has been researched along with 1,2-dipalmitoylphosphatidylcholine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canaves, JM; Ferragut, JA; Gonzalez-Ros, JM | 1 |
| Romsicki, Y; Sharom, FJ | 1 |
| Belli, S; Elsener, PM; Krämer, SD; Wunderli-Allenspach, H | 1 |
3 other study(ies) available for verapamil and 1,2-dipalmitoylphosphatidylcholine
| Article | Year |
|---|---|
Verapamil prevents the effects of daunomycin on the thermotropic phase transition of model lipid bilayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Calorimetry, Differential Scanning; Daunorubicin; Diphenylhexatriene; Fluorescence Polarization; Lipid Bilayers; Liposomes; Thermodynamics; Verapamil | 1991 |
The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenosine Triphosphatases; Anilino Naphthalenesulfonates; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; CHO Cells; Cricetinae; Dimyristoylphosphatidylcholine; Drug Interactions; Enzyme Inhibitors; Humans; Membrane Lipids; Phosphatidylcholines; Protein Binding; Receptors, Drug; Spectrometry, Fluorescence; Sulfhydryl Reagents; Verapamil; Vinblastine | 1999 |
Cholesterol-mediated activation of P-glycoprotein: distinct effects on basal and drug-induced ATPase activities.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Adenosine Triphosphatases; Adrenergic alpha-Agonists; alpha-Tocopherol; Animals; Anisotropy; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Line, Tumor; Cholesterol; Enzyme Induction; Excipients; Lipid Bilayers; Liposomes; Membranes, Artificial; Mice; Propanolamines; Verapamil; Vinblastine | 2009 |